Ankui Yang

673 total citations
25 papers, 442 citations indexed

About

Ankui Yang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ankui Yang has authored 25 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Ankui Yang's work include Cancer-related gene regulation (8 papers), RNA modifications and cancer (6 papers) and Head and Neck Cancer Studies (6 papers). Ankui Yang is often cited by papers focused on Cancer-related gene regulation (8 papers), RNA modifications and cancer (6 papers) and Head and Neck Cancer Studies (6 papers). Ankui Yang collaborates with scholars based in China, Canada and United States. Ankui Yang's co-authors include Huayong Zhang, Xiaoyan Fu, Xuan Su, Yao Fan, Yan Fu, Wei‐Chao Chen, Jianmin Liu, Dian Ouyang, Yize Mao and Quan Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Ankui Yang

24 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ankui Yang China 15 253 167 147 73 72 25 442
Srikant Ambatipudi India 10 250 1.0× 102 0.6× 77 0.5× 35 0.5× 54 0.8× 17 380
Shinji Mikami Japan 9 108 0.4× 77 0.5× 147 1.0× 33 0.5× 32 0.4× 20 305
Lijuan Bian China 11 157 0.6× 130 0.8× 52 0.4× 24 0.3× 40 0.6× 19 311
Jugao Fang China 11 201 0.8× 105 0.6× 64 0.4× 33 0.5× 54 0.8× 30 313
Kevin Furlong United States 6 103 0.4× 47 0.3× 207 1.4× 39 0.5× 77 1.1× 14 381
Xinhong Wang China 11 246 1.0× 179 1.1× 38 0.3× 11 0.2× 37 0.5× 16 332
Haiyan Dai China 11 232 0.9× 130 0.8× 75 0.5× 8 0.1× 28 0.4× 22 374
Minghan Jia China 10 133 0.5× 127 0.8× 206 1.4× 5 0.1× 102 1.4× 21 394
Ryota Masuda Japan 11 72 0.3× 49 0.3× 121 0.8× 16 0.2× 163 2.3× 53 371

Countries citing papers authored by Ankui Yang

Since Specialization
Citations

This map shows the geographic impact of Ankui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankui Yang more than expected).

Fields of papers citing papers by Ankui Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankui Yang. The network helps show where Ankui Yang may publish in the future.

Co-authorship network of co-authors of Ankui Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ankui Yang. A scholar is included among the top collaborators of Ankui Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankui Yang. Ankui Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wenlin, Jie Wu, Siyi Zhang, et al.. (2024). NID1 promotes laryngeal cancer stemness via activating WNT pathway. Biology Direct. 19(1). 115–115.
2.
Jiang, Mingjie, Yongchao Yu, & Ankui Yang. (2024). Concerns Regarding Thermal Ablation for Papillary Thyroid Cancer. JAMA Surgery. 159(11). 1231–1231. 2 indexed citations
3.
Jiang, Mingjie, Zhongyuan Yang, Juanjuan Dai, et al.. (2023). Intratumor microbiome: selective colonization in the tumor microenvironment and a vital regulator of tumor biology. SHILAP Revista de lepidopterología. 4(5). e376–e376. 13 indexed citations
4.
Wu, Tong, et al.. (2022). CDH3 is associated with poor prognosis by promoting the malignancy and chemoresistance in oral squamous cell carcinoma. Asian Journal of Surgery. 45(12). 2651–2658. 8 indexed citations
5.
Qian, Long, Chunyu Huang, Meng Qi, et al.. (2021). TNF Patterns and Tumor Microenvironment Characterization in Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology. 12. 754818–754818. 11 indexed citations
6.
Li, Yixuan, et al.. (2021). BASP1 is up-regulated in tongue squamous cell carcinoma and associated with a poor prognosis. Asian Journal of Surgery. 45(5). 1101–1106. 6 indexed citations
7.
Liu, Hui, Pei Li, Haifeng Wang, et al.. (2020). miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78. Frontiers in Oncology. 10. 60–60. 33 indexed citations
8.
Li, Hao, Xiaoyan Fu, Yao Fan, et al.. (2019). MTHFD1L-Mediated Redox Homeostasis Promotes Tumor Progression in Tongue Squamous Cell Carcinoma. Frontiers in Oncology. 9. 1278–1278. 20 indexed citations
9.
Li, Qiuli, et al.. (2019). Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling. Journal of Experimental & Clinical Cancer Research. 38(1). 167–167. 25 indexed citations
10.
Zhang, Qingbin, Xingyang Li, Xuan Su, et al.. (2019). HNCDB: An Integrated Gene and Drug Database for Head and Neck Cancer. Frontiers in Oncology. 9. 371–371. 9 indexed citations
11.
Chen, Yue, Tian Tian, Zhiyong Li, et al.. (2019). FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma. Cell Death and Disease. 10(5). 356–356. 30 indexed citations
12.
Li, Qiuli, Wei‐Chao Chen, Ming Song, et al.. (2019). Weighted gene co-expression network analysis and prognostic analysis identifies hub genes and the molecular mechanism related to head and neck squamous cell carcinoma. Cancer Biology & Therapy. 20(6). 750–759. 8 indexed citations
13.
Li, Pei, Zihao Xing, Jinming Di, et al.. (2018). Inhibition of WEE1 Suppresses the Tumor Growth in Laryngeal Squamous Cell Carcinoma. Frontiers in Pharmacology. 9. 1041–1041. 21 indexed citations
14.
Chen, Wei‐Chao, et al.. (2018). Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway. European Journal of Pharmacology. 839. 33–39. 16 indexed citations
15.
Fu, Xiaoyan, Shuwei Chen, Wei‐Chao Chen, et al.. (2018). Clinical analysis of second primary gingival squamous cell carcinoma after radiotherapy. Oral Oncology. 84. 20–24. 16 indexed citations
17.
Mao, Yize, et al.. (2017). Platelet-to-lymphocyte ratio predicts long-term survival in laryngeal cancer. European Archives of Oto-Rhino-Laryngology. 275(2). 553–559. 23 indexed citations
18.
Zhang, Huayong, Jianmin Liu, Xiaoyan Fu, & Ankui Yang. (2017). Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis. Medical Science Monitor. 23. 5924–5932. 36 indexed citations
19.
Fu, Yan, Wei Wei Liu, Dian Ouyang, Ankui Yang, & Quan Zhang. (2016). Preoperative Neutrophil-to-lymphocyte Ratio Predicts Long-term Survival in Patients Undergoing Total Laryngectomy With Advanced Laryngeal Squamous Cell Carcinoma. Medicine. 95(6). e2689–e2689. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026